Literature DB >> 17336577

Glucocorticoids in the regulation of transcription factors that control cytokine synthesis.

Ana C Liberman1, Jimena Druker, Marcelo J Perone, Eduardo Arzt.   

Abstract

The interaction at different levels between intracellular signals elicited by cytokines and activated glucocorticoid receptors (GR) is essential for the regulation of immune responses. We describe different levels of interaction between glucocorticoids and cytokines which result in the induction or repression of gene transcription. These include the regulation of cytokine receptor expression, the molecular cross-talk between the GR and transcription factors (TFs) activated by cytokine signaling, the interaction with several signaling pathways and also posttranslational modifications of both GR and TFs. Also, an overview of the implications of chromatin remodeling in this interplay is discussed. The complexity of the intricate network involved in the interaction between GR and TFs is pivotal for the final outcome of cytokines biological action.

Mesh:

Substances:

Year:  2007        PMID: 17336577     DOI: 10.1016/j.cytogfr.2007.01.005

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  37 in total

1.  Differential pharmacological behaviour of p38 inhibitors in regulating the LPS-induced TNF-α production in human and rat whole blood in vitro.

Authors:  Mercè Pont-Giralt; Núria Godessart; Cristina Balagué
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

Review 2.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

3.  Effects of high-dose corticosteroids on post-traumatic inflammatory mediators.

Authors:  Olav Reikerås; Arthur Helle; Claus Danckert Krohn; Jens Ivar Brox
Journal:  Inflamm Res       Date:  2009-06-28       Impact factor: 4.575

4.  Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach.

Authors:  Samith Rathnayake; Samantha Weerasinghe
Journal:  J Mol Model       Date:  2018-11-20       Impact factor: 1.810

Review 5.  Nongenomic actions of adrenal steroids in the central nervous system.

Authors:  N K Evanson; J P Herman; R R Sakai; E G Krause
Journal:  J Neuroendocrinol       Date:  2010-03-27       Impact factor: 3.627

Review 6.  Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases.

Authors:  Rowan S Hardy; Karim Raza; Mark S Cooper
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

Review 7.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.

Authors:  A Sasha Tait; Cherie L Butts; Esther M Sternberg
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

Review 8.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

9.  Transrepression function of the glucocorticoid receptor regulates eyelid development and keratinocyte proliferation but is not sufficient to prevent skin chronic inflammation.

Authors:  Eva Donet; Pilar Bosch; Ana Sanchis; Pilar Bayo; Angel Ramírez; José L Cascallana; Ana Bravo; Paloma Pérez
Journal:  Mol Endocrinol       Date:  2008-01-03

10.  Gene regulation system of vasopressin and corticotropin-releasing hormone.

Authors:  Masanori Yoshida
Journal:  Gene Regul Syst Bio       Date:  2008-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.